# Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes

> **NCT01831765** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 1290 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Faster-acting insulin aspart
- **DRUG:** insulin detemir
- **DRUG:** insulin aspart
- **DRUG:** Faster-acting insulin aspart

## Key facts

- **NCT ID:** NCT01831765
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-26
- **Primary completion:** 2015-05-12
- **Final completion:** 2015-06-11
- **Target enrollment:** 1290 (ACTUAL)
- **Last updated:** 2019-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01831765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01831765, "Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT01831765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*